
Pearl River, New York
Research Site
Pearl River, NY Site Statistics:
- Dating back to 1907, when Dr. Ernst Lederle established the facility to produce a life-saving treatment for children with diphtheria, Pfizer’s Pearl River site continues a legacy of scientific innovation spanning more than a century.
- Encompassing approximately 330 acres overall, including 23 acres of developed campus, Pfizer’s Pearl River site is home to more than 1,000 colleagues working across a vibrant, multi-building hub spanning research and development, manufacturing, and enabling functions.
- Serving as the primary global R&D hub for Pfizer Vaccines, the Pearl River campus advances pioneering vaccines designed to prevent serious infectious diseases and help protect diverse populations worldwide, building on more than a century of expertise in vaccine discovery, development, and clinical science.
Beyond its leadership in vaccine innovation, the site is a key part of Pfizer’s global manufacturing network, with specialized capabilities in the production of antibody-drug conjugates (ADCs) and other advanced modalities that reflect a long-standing legacy of manufacturing excellence.
Learn more about career opportunities in Pearl River.





